See more : Jiangxi Copper Company Limited (0358.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Zota Health Care Limited (ZOTA.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zota Health Care Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- MDwerks, Inc. (MDWK) Income Statement Analysis – Financial Results
- RISMA Systems A/S (RISMA.CO) Income Statement Analysis – Financial Results
- Basler Aktiengesellschaft (BSL.DE) Income Statement Analysis – Financial Results
- CellaVision AB (publ) (CLVSF) Income Statement Analysis – Financial Results
- Anglo African Agriculture Plc (AAAP.L) Income Statement Analysis – Financial Results
Zota Health Care Limited (ZOTA.NS)
About Zota Health Care Limited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.80B | 1.40B | 1.31B | 1.07B | 951.13M | 856.29M | 778.52M | 715.80M | 647.33M | 564.63M | 501.12M | 439.08M | 381.43M |
| Cost of Revenue | 1.00B | 832.70M | 893.07M | 757.47M | 685.49M | 593.18M | 533.99M | 451.49M | 447.07M | 392.04M | 361.49M | 318.67M | 276.53M |
| Gross Profit | 803.38M | 566.87M | 418.86M | 310.42M | 265.64M | 263.12M | 244.52M | 264.31M | 200.26M | 172.60M | 139.63M | 120.41M | 104.90M |
| Gross Profit Ratio | 44.51% | 40.50% | 31.93% | 29.07% | 27.93% | 30.73% | 31.41% | 36.92% | 30.94% | 30.57% | 27.86% | 27.42% | 27.50% |
| Research & Development | 7.00K | 600.00K | 5.00K | 201.00K | 1.66M | 918.00K | 1.06M | 497.92K | 365.60K | 325.00K | 260.00K | 162.00K | 0.00 |
| General & Administrative | 280.64M | 201.54M | 81.20M | 68.67M | 53.97M | 45.99M | 31.71M | 26.24M | 16.72M | 15.14M | 13.94M | 9.63M | 11.77M |
| Selling & Marketing | 132.17M | 139.34M | 78.43M | 133.16M | 50.91M | 37.91M | 33.80M | 46.01M | 33.16M | 26.52M | 24.66M | 20.04M | 15.99M |
| SG&A | 412.81M | 340.88M | 159.63M | 201.82M | 104.89M | 83.90M | 65.51M | 72.25M | 49.87M | 41.65M | 38.61M | 29.66M | 27.76M |
| Other Expenses | 390.58M | 19.56M | 77.00K | 276.00K | 493.00K | 1.37M | 88.01K | 77.85K | 66.44M | 61.24M | 47.41M | 45.26M | 16.00K |
| Operating Expenses | 803.38M | 613.09M | 306.84M | 331.89M | 239.87M | 197.45M | 144.87M | 174.42M | 116.31M | 102.89M | 86.02M | 74.92M | 70.51M |
| Cost & Expenses | 1.93B | 1.45B | 1.20B | 1.09B | 925.35M | 790.63M | 678.87M | 625.91M | 563.38M | 494.93M | 447.51M | 393.59M | 347.04M |
| Interest Income | 9.48M | 8.82M | 12.67M | 7.03M | 10.49M | 14.07M | 14.77M | 55.70K | 613.00K | 144.00K | 162.00K | 176.00K | 256.00K |
| Interest Expense | 47.88M | 25.64M | 141.00K | 504.00K | 136.00K | 368.03K | 1.09M | 6.62M | 6.40M | 6.29M | 6.68M | 7.64M | 4.63M |
| Depreciation & Amortization | 201.71M | 119.57M | 36.71M | 31.69M | 20.98M | 13.94M | 9.37M | 10.54M | 12.35M | 15.06M | 12.07M | 13.51M | 13.87M |
| EBITDA | 82.07M | 98.05M | 164.26M | 28.63M | 60.15M | 92.66M | 123.99M | 100.51M | 95.65M | 84.84M | 65.16M | 59.34M | 48.12M |
| EBITDA Ratio | 4.55% | 6.64% | 12.29% | 1.71% | 6.28% | 11.10% | 15.94% | 14.07% | 14.92% | 14.97% | 13.11% | 13.41% | 12.62% |
| Operating Income | -126.13M | -38.27M | 112.05M | -21.29M | 25.32M | 64.74M | 114.71M | 90.18M | 84.21M | 69.49M | 53.64M | 45.38M | 34.25M |
| Operating Income Ratio | -6.99% | -2.73% | 8.54% | -1.99% | 2.66% | 7.56% | 14.73% | 12.60% | 13.01% | 12.31% | 10.70% | 10.34% | 8.98% |
| Total Other Income/Expenses | -35.50M | -46.91M | -161.66M | -3.65M | 13.78M | 12.89M | -1.29M | -7.27M | -6.29M | -6.51M | -6.64M | -7.59M | -4.78M |
| Income Before Tax | -161.63M | -46.91M | 124.35M | -3.65M | 38.62M | 78.56M | 113.42M | 83.62M | 77.89M | 63.20M | 46.97M | 37.90M | 29.62M |
| Income Before Tax Ratio | -8.96% | -3.35% | 9.48% | -0.34% | 4.06% | 9.17% | 14.57% | 11.68% | 12.03% | 11.19% | 9.37% | 8.63% | 7.76% |
| Income Tax Expense | -18.15M | 10.82M | 35.31M | -1.57M | 11.20M | 23.07M | 40.74M | 28.21M | 26.03M | 20.60M | 15.67M | 12.35M | 9.78M |
| Net Income | -143.48M | -57.73M | 89.08M | -2.09M | 27.42M | 55.48M | 72.68M | 55.41M | 51.86M | 42.60M | 31.30M | 25.55M | 19.83M |
| Net Income Ratio | -7.95% | -4.12% | 6.79% | -0.20% | 2.88% | 6.48% | 9.34% | 7.74% | 8.01% | 7.55% | 6.25% | 5.82% | 5.20% |
| EPS | -5.55 | -2.29 | 3.58 | -0.09 | 1.12 | 2.26 | 3.02 | 2.76 | 2.54 | 2.12 | 1.56 | 1.27 | 0.99 |
| EPS Diluted | -5.55 | -2.29 | 3.58 | -0.09 | 1.12 | 2.26 | 3.02 | 2.76 | 2.54 | 2.12 | 1.56 | 1.27 | 0.99 |
| Weighted Avg Shares Out | 25.85M | 25.16M | 24.88M | 24.56M | 24.56M | 24.56M | 24.07M | 20.11M | 20.11M | 20.11M | 20.11M | 20.11M | 20.11M |
| Weighted Avg Shares Out (Dil) | 25.85M | 25.16M | 24.88M | 24.56M | 24.56M | 24.56M | 24.07M | 24.56M | 24.56M | 24.56M | 24.56M | 24.56M | 24.56M |
Source: https://incomestatements.info
Category: Stock Reports
How has Zota Health Care’s net profit margin changed?
The ratio/financial analysis of ZOTA HEALTH CARE reveals: Operating profit margins witnessed a fall and stood at 4.2% in FY24 as against 5.2% in FY23. Net profit margins declined from 4.1% in FY23 to 8.0% in FY24.